TissueGene
Jung In Kim joined Kolon TissueGene, Inc. in December, 2021 as the Chief Financial Officer and the Korea Branch leader. Before she joined Kolon TissueGene, she served as a director of the Management and Finance division in Kolon Corporation. She received his Bachelor of Arts in Mathematics at Kookmin University in Korea and acquired her CPA license from Korea Institute of Certified Public Accountant.
This person is not in any offices
TissueGene
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders.